Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
  1. 4 Open-market sale Principal Accounting Officer sold 250 shares at $39.93 ($9,983)
  2. 4 Derivatives Options or other derivatives
  3. 4 Exercise or conversion Director acquired 1,878 shares (option exercise)
  4. 4 Exercise or conversion Director acquired 1,878 shares (option exercise)
  5. 4 Exercise or conversion Director acquired 1,878 shares (option exercise)
  6. 4 Exercise or conversion Director acquired 1,878 shares (option exercise)
  7. 4 Exercise or conversion Director acquired 1,878 shares (option exercise)
  8. 4 Exercise or conversion Director acquired 1,878 shares (option exercise)
  9. 4 Open-market sale Chief Medical Officer sold 3,583 shares at $50.01 ($179,200)
  10. 4 Shares withheld for taxes Chief Financial Officer gave up 1,927 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chief Legal Officer gave up 2,529 shares (to pay taxes)
  12. 4 Shares withheld for taxes Chief Financial Officer gave up 1,599 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief Executive Officer gave up 3,673 shares (to pay taxes)
  14. 4 Shares withheld for taxes Chief Scientific Officer gave up 2,027 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Medical Officer gave up 2,368 shares (to pay taxes)
  16. 4 Open-market sale Principal Accounting Officer sold 345 shares at $47.30 ($16,319)
  17. 4 Gift Director gave 4,315 shares (gift)
  18. 4 Open-market sale Principal Accounting Officer sold 472 shares at $47.12 ($22,241)
  19. 4 Shares withheld for taxes Chief Financial Officer gave up 1,056 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief Medical Officer gave up 1,596 shares (to pay taxes)

Page 16 of 38 · 758 filings